西他列汀与吡格列酮联合使用后黑棘皮病的消退
Regression of Acanthosis Nigricans with the Addition of Sitagliptin and Pioglitazone.
作者信息
Adderley-Rolle E M, Peter S
机构信息
Department of Medicine, Princess Margaret Hospital, Shirley Street, Nassau, Bahamas.
出版信息
West Indian Med J. 2015 Mar;64(2):160-1. doi: 10.7727/wimj.2013.334. Epub 2014 Oct 16.
Abstract
Acanthosis nigricans (AN) is a cutaneous disorder associated with various diseases. There are few documented cases of regression of AN. We discuss a case of a 48-year old diabetic woman with resolution of AN after treatment with sitagliptin and pioglitazone.
摘要
黑棘皮病（AN）是一种与多种疾病相关的皮肤疾病。AN消退的病例记录很少。我们讨论一例48岁的糖尿病女性患者，在使用西他列汀和吡格列酮治疗后黑棘皮病消退的病例。
相似文献
1
Regression of Acanthosis Nigricans with the Addition of Sitagliptin and Pioglitazone.西他列汀与吡格列酮联合使用后黑棘皮病的消退
West Indian Med J. 2015 Mar;64(2):160-1. doi: 10.7727/wimj.2013.334. Epub 2014 Oct 16.
2
Malignant acanthosis nigricans associated with non-Hodgkin's lymphoma. Report of 2 cases.与非霍奇金淋巴瘤相关的恶性黑棘皮病。2例报告。
Dermatologica. 1988;176(3):133-7.
3
[Woman 19-old with hirsutism, obesity and acanthosis nigricans].[19岁患有多毛症、肥胖症和黑棘皮病的女性]
Pol Merkur Lekarski. 2016 Sep 29;41(243):141-144.
4
[Acanthosis nigricans in children and Crouzon syndrome].[儿童黑棘皮病与克鲁宗综合征]
Ann Dermatol Venereol. 2014 Nov;141(11):685-8. doi: 10.1016/j.annder.2014.06.020. Epub 2014 Aug 7.
5
Cutaneous features of Crouzon syndrome with acanthosis nigricans.Crouzon 综合征伴黑棘皮病的皮肤特征。
JAMA Dermatol. 2013 Jun;149(6):737-41. doi: 10.1001/jamadermatol.2013.3019.
6
Acanthosis nigricans with endometrial carcinoma: case report and review of the literature.黑棘皮症合并子宫内膜癌：病例报告及文献复习
Gynecol Oncol. 2002 Feb;84(2):332-4. doi: 10.1006/gyno.2001.6472.
7
Oral acanthosis nigricans: report of a case and comparison of oral and cutaneous pathology.口腔黑棘皮病：一例报告及口腔与皮肤病理学比较
Am J Dermatopathol. 1988 Feb;10(1):68-73.
8
Malignant acanthosis nigricans associated with prostate cancer: a case report.与前列腺癌相关的恶性黑棘皮病：一例报告
BMC Urol. 2014 Nov 15;14:88. doi: 10.1186/1471-2490-14-88.
9
[Scleredema, acanthosis nigricans and IgA/Kappa multiple myeloma].[硬化性水肿、黑棘皮病与IgA/κ多发性骨髓瘤]
Ann Dermatol Venereol. 1997;124(8):537-9.
10
[Acanthosis nigricans in pregnancy].[妊娠期黑棘皮病]
G Ital Dermatol Venereol. 1989 Nov-Dec;124(11-12):511-5.
引用本文的文献
1
Global hotspots and trends in Acanthosis nigricans research: A bibliometric and visualized analysis.全球黑棘皮病研究的热点和趋势：文献计量学和可视化分析。
Skin Res Technol. 2024 Sep;30(9):e70054. doi: 10.1111/srt.70054.
2
Review of facial acanthosis nigricans: Easy to diagnose and difficult to treat marker of hyperinsulinemia/metabolic syndrome.面部黑棘皮病综述：高胰岛素血症/代谢综合征易于诊断但难以治疗的标志物
Med J Armed Forces India. 2024 May-Jun;80(3):257-269. doi: 10.1016/j.mjafi.2024.04.011. Epub 2024 Apr 26.
3
Effectiveness and Safety of Metformin versus Canthex™ in Patients with Acanthosis Nigricans: A Randomized, Double-blind Controlled Trial.二甲双胍与Canthex™治疗黑棘皮病患者的有效性和安全性：一项随机双盲对照试验
Indian J Dermatol. 2019 Mar-Apr;64(2):115-121. doi: 10.4103/ijd.IJD_417_17.
4
Current treatment options for acanthosis nigricans.黑棘皮病的当前治疗选择。
Clin Cosmet Investig Dermatol. 2018 Aug 7;11:407-413. doi: 10.2147/CCID.S137527. eCollection 2018.
本文引用的文献
1
Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome.黑棘皮病的消退与B型胰岛素抵抗综合征中抗胰岛素受体自身抗体的消失及血糖正常的实现相关。
Metabolism. 2007 May;56(5):670-5. doi: 10.1016/j.metabol.2006.12.016.
2
Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans.胰岛素与胰岛素样生长因子受体的过度结合：黑棘皮病的潜在机制。
J Invest Dermatol. 1992 Jun;98(6 Suppl):82S-85S. doi: 10.1111/1523-1747.ep12462293.
3
The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man.胰岛素抵抗与黑棘皮症综合征。人类的胰岛素受体疾病。
N Engl J Med. 1976 Apr 1;294(14):739-45. doi: 10.1056/NEJM197604012941401.
Zotero 插件